BCAB 8-K 2026-09-29
BioAtla, Inc. (BCAB) 8-K dated 2026-09-29 — accession 0001193125-26-407817.
BioAtla, Inc. (BCAB) is a biotechnology company listed on NASDAQ.
BioAtla, Inc. filed a 8-K on 2026-09-29. Accession 0001193125-26-407817.
This 8-K covers: Director/officer change (Item 5.02), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported BCAB revenue for 2023-09-30 was $0. Net income was -$33.3M. BCAB currently screens at market cap $5.9M.
Not investment advice. The BCAB SEC hub lists recent forms. The stock page is the research view.